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Primary health care 
A B S T R A C T   
The study had a three-fold objective: (i) to estimate the amenable mortality rates and trends at a national and 
state level between 2000 and 2015 in Mexico; (ii) to estimate the contribution and trends of various causes of 
death to overall amenable mortality; and (iii) to determine the association between health system inputs and 
amenable mortality for the period 2000–2015. We used a panel dataset for the period 2000–2015. The following 
health care inputs were used in the analysis: density of general practitioners, specialists and nurses, as well as 
density of hospital beds. We find that amenable mortality fell from 136 per 100,000 in 2000, to 124.1 per 
100,000 in 2015 nationally, with significant heterogeneity in the trends across states. Mortality due to infectious 
diseases, diseases of childhood, and cardiovascular diseases decreased, while deaths due to other non- 
communicable diseases, such as diabetes, increased. There was a significant negative association between the 
density of general practitioners and specialist physicians, and amenable mortality. Our results indicate that 
reducing the burden of non-communicable diseases must be a health system priority. Improvements in primary 
health care could lead to improved disease detection and earlier diagnosis which could further reduce amenable 
mortality in Mexico.   
1. Introduction 
It has been more than 15 years since the introduction of Seguro 
Popular (SP), a public health insurance scheme for uninsured people in 
Mexico. The introduction of SP has been associated with improved ac-
cess to health care. According to the National Council for the Evaluation 
of Social Development Policy (CONEVAL), 57.3 million individuals ac-
cess affordable health care through SP (CONEVAL, 2014) the majority of 
whom belong to the four poorest deciles of the population (Knaul et al., 
2005). SP was rolled out gradually starting in 2003, and by 2005, all 32 
Mexican states were enrolled; it complemented the existing social se-
curity programmes (Frenk, 2005; Knaul and Frenk, 2005). The SP has no 
restrictions based on current health status or pre-existing illness, and no 
co-payments according to type of health care. Moreover, contributions 
to SP are based on households’ ability to pay: households classified in 
the first two income deciles are exempt from any annual payment, while 
those belonging to higher deciles make an annual contribution (Knaul 
and Frenk, 2005). The total benefits package under SP expanded 
significantly over time. In 2005, it covered 172 interventions, which 
increased to 336 by 2012, thus potentially affecting health care utili-
zation rates (Mathauer and Behrendt, 2017). The roll-out of SP was 
accompanied by progress in key health indicators such as maternal and 
infant mortality and reduced deaths from communicable and 
nutrition-related illnesses (Agudelo-Botero and Dávila-Cervantes, 
2014). 
In concert with the introduction of SP, the Mexican government 
steadily increased its investment in the public health care system from 
2.6% of the gross domestic product (GDP) in 2004, to 3.2% of GDP in 
2014 (Secretaria de Salud - SSA, 2014). The increased public spending 
was coupled with improvements in the health infrastructure, with the 
construction of 2284 outpatient clinics and 262 community, general, 
and specialized hospitals between 2001 and 2006 (Conti and Ginja, 
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2017). In addition, access to general practitioners, specialist physicians, 
nurses, and hospital beds increased over this period (Knaul et al., 2012). 
Furthermore, the number of general practitioners (GPs) and specialist 
physicians per capita increased by 36% and 40% respectively between 
2000 and 2013 (INEGI, 2019). 
However, it is still unclear whether the additional expenditure on 
health care resulted in better population health outcomes. For example, 
while there was a gradual reduction in the catastrophic health care 
expenditure (expenditure on health care representing over 25% of total 
household budget) (Ávila-Burgos et al., 2013; King et al., 2009), the rate 
of reduction declined over time (Nikoloski and Mossialos, 2018). Since 
the early 2000s, the prevalence of obesity has reached epidemic pro-
portions nationally (OECD, 2017). These factors have contributed to 
slow growth in life expectancy over the past decade compared to other 
Organization of Economic Cooperation and Development (OECD) 
countries. Consequently, in 2016 there was a 5.5-year life expectancy 
gap between Mexico and the OECD average, an increase from a 4.2-year 
gap in 2006 (OECD, 2017). Furthermore, there are substantial in-
equalities in health status. The most marginalized states with the highest 
proportion of indigenous people have poorer health outcomes than the 
other states (PAHO, 2012). More specifically, children under the age of 5 
in these states are 1.7 times more likely to die (PAHO, 2012). 
Avoidable mortality can be used as an indicator of health system 
performance, but this topic has received limited attention in Mexico. 
The concept of avoidable mortality has been around since the late 1970s 
(Beltrán-Sánchez, 2011). It was first coined by Rutstein et al. (1976) as 
an alternative measure of quality of health care and was based on the 
notion that if everything goes well in the medical system, deaths due to 
certain conditions should not occur. Subsequently, the idea received 
significant interest among researchers resulting with a handful of 
studies, mainly based on US and European data (Charlton et al., 1983; 
Holland et al., 1994; Newey et al., 2004). Over the years, when studying 
the concept of avoidable mortality, researchers started to distinguish 
between ‘amenable’ deaths (i.e. deaths due to conditions amenable to 
medical interventions) and ‘preventable’ deaths (i.e. deaths due to 
conditions that can be prevented by system-wide health policies). In 
other words, a death can be considered as amenable if it could have been 
avoided through optimal quality health care (Nolte and McKee, 2004). 
Preventable deaths, on the other hand, is a broader concept and includes 
deaths which could have been avoided by public health interventions 
focusing on wider determinants of public health, such as behaviour and 
lifestyle factors, socioeconomic status and environmental factors (Nolte 
and McKee, 2004). The concept of amenable mortality, although 
sometimes used interchangeably with avoidable mortality, is intended 
to focus solely on conditions that capture the impact of medical care 
(Nolte and McKee, 2004). 
Amenable mortality ties health system performance to a variety of 
diseases that should not result in death given the state of medical 
knowledge and technology (Kossarova et al., 2013). In a seminal study, 
Franco Marina et al.(Franco Marina et al., 2006) estimated the level and 
trends of avoidable mortality in Mexico at the national and state level 
between 1990–1994 and 2000–2004 by specific disease, age group, sex, 
and income disparity, and found a drop in avoidable mortality of 3% 
between the two periods. In addition, they found that 39% of all deaths 
were avoidable, 65% of which were due to non-communicable diseases 
(NCDs), followed by infectious disease, nutrition and reproductive 
conditions. Additionally, NCDs accounted for an increasing percentage 
of overall avoidable mortality over time. This is echoed in a study by 
Canudas-Romo et al. (2015) who found that certain NCDs (e.g. diabetes) 
are associated with shorter life expectancy in Mexico. In contrast, 
Agudelo-Botero & Davila-Cervantes (Agudelo-Botero and 
Dávila-Cervantes, 2014) found a 2.1% increase in the age-adjusted 
amenable mortality rate from 149.5 per 100,000 inhabitants in 2001 
to 171.3 per 100,000 inhabitants in 2010. However, when considering 
only states on the Mexico–US border, Agudelo-Botero et al. (Agueldo--
Botero et al., 2015) estimated that there had been a 9.1% decrease in 
amenable mortality between 1999–2001 and 2009–2011. The in-
consistencies in these findings may be attributed to differing lists of 
causes of avoidable or amenable mortality, regional disparities in health 
outcomes, and geographic heterogeneity. Franco Marina et al. (Franco 
Marina et al., 2006) use a broad definition of avoidable mortality and 
include conditions both amenable to medical care and preventable by 
wider policy changes such as lung cancer and HIV. In contrast, 
Agudelo-Botero & Davila-Cervantes (Agudelo-Botero and 
Dávila-Cervantes, 2014) and Agudelo-Botero et al.(Agueldo-Botero 
et al., 2015) use a definition based on Nolte and McKee (2012), which 
included only causes of death amenable to medical interventions. 
However, while most previous studies have focused on describing 
avoidable or amenable mortality and its trends, none of them have 
assessed the associations between amenable mortality and its 
determinants. 
Given this background, this study had three objectives:  
1. To estimate the amenable mortality rates and trends at a national and 
state level between 2000 and 2015 in Mexico;  
2. To estimate the contribution and trends of various causes of death to 
overall amenable mortality; and  
3. To determine the association between health system inputs and 
amenable mortality for the period 2000–2015. In particular we are 
interested in a set of health inputs which are associated with 
increased healthcare expenditure. 
This last objective was designed to ascertain whether increased in-
vestments in the public health care sector were associated with 
commensurate improvements in health outcomes. 
2. Methods 
2.1. Determining amenable mortality at state level 
The data used to estimate the age-standardized amenable mortality 
rate and its individual components was collected from the following 
official sources: 
(1) General deaths by specific condition, published by the National 
Institute of Statistics and Geography (INEGI, 2019), to allow for the 
bottom-up approach we have taken (while we also considered using the 
aggregate CONAPO data for sensitivity analysis, this was not possible, 
given the bottom-up approach adopted and the narrower definition of 
amenable mortality); (2) population by age group from 1990 to 2015, 
published by the National Population Council (CONAPO, 2016); and (3) 
population standardization factors from the WHO World Standard 
Population ratios (World Health Organization, 2001). 
The deaths were classified as amenable deaths based on an estab-
lished list of conditions considered amenable to medical care (Nolte and 
McKee, 2012) (Table 1). The study’s focus on amenable mortality means 
that we have not included mortality due to conditions that could be 
prevented through health policies or other system-wide policies (e.g. 
deaths due to homicides or lack of access to water and sanitation) 
although some research has focused on these (Elo et al., 2014; Alvarez 
et al., 2019; Aburto et al., 2016). Inter alia, we considered conditions 
such as selected childhood infections, diabetes, treatable cancers, cere-
brovascular disease, and hypertension as amenable mortality (Nolte and 
McKee, 2012). We also included 50% of deaths due to ischaemic heart 
disease as deaths amenable to medical intervention (Nolte and McKee, 
2012). We only take half of the deaths due to ischaemic heart disease as 
the other half of deaths could have been prevented by more general, 
system-wide health policies (Nolte and McKee, 2012). The upper age 
limit of the registered death was set to 75 years, while younger age limits 
were applied to selected conditions such as diabetes (under 50), certain 
childhood infectious intestinal and respiratory diseases (under 15), and 
leukaemia (under 45) (Nolte and McKee, 2012). Different age limits 
were set for diabetes as preventability of deaths at older ages from 
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diabetes, and in particular the effectiveness of good diabetic control in 
reducing vascular complications, remain controversial (Nolte and 
McKee, 2012). 
The causes of death were classified according to the International 
Statistical Classification of Diseases and Related Health Problems 10th 
Revision (ICD-10) (ICD-10, 2016). The age-standardized amenable 













where, AM is the amenable mortality; dx is the number of deaths in age 
group x by number or condition; px is the population in age group x; and 
Px is the proportion of the population in age group x relative to the 
standard population. Numbers of deaths were calculated based on the 
data as it was reported. The causes of deaths we are using for the analysis 
are precisely specified and refer to deaths below the age of 75, thus 
reducing the chance of including so-called ‘garbage codes’. The age- 
standardized mortality rates were calculated for the entire country as 
well as on a state level. The age-standardized mortality rates were also 
calculated for the main types of amenable mortality. 
2.2. Panel data analysis using system Generalized Method of Moments 
Apart from calculating the amenable mortality rates, we aimed to 
estimate the association between health system supply-side factors and 
amenable mortality. To date, there have been some efforts to model the 
determinants of mortality (Basu et al., 2019; Gerry et al., 2014). Some of 
these, however, could not be directly replicated in our case for the 
following reasons. First, the use of a mixed effects model still doesn’t 
address the endogeneity issue and should therefore be coupled with an 
instrumental variable approach – an extremely difficult endeavour in the 
context of a middle-income country. Second, we were interested in the 
wider set of ‘determinants’ while focusing on health care supply vari-
ables, particularly those that are a function of increased healthcare 
expenditure. Hence, our methodological approach was appropriate to 
the objectives that we wanted to achieve. We used three statistical 
models to assess the associations between health system supply and 
amenable mortality: 1) Model 1 used ordinary least squares (OLS); 2) 
Model 2 used fixed effects regression; and 3) Model 3 used the system 
Generalized Method of Moments (system-GMM). The OLS and fixed 
effects represented the upper and lower bounds respectively for the 
coefficient of the autoregressive term (Bond, 2002). 
We constructed a panel data set for all 32 states, from 2000 to 2015, 
using data from official government sources. We used the following 
equation to estimate overall population health: 
AMit = β0 + β1Xit + εit  
where the logarithm of the age-adjusted amenable mortality, AMit, in 
state i at time t is a function of the health input variables (X). In making 
these calculations, we took into account, firstly, that the state-specific 
amenable mortality rates are based on previous estimates, and sec-
ondly, that some explanatory variables are endogenous (Gerry et al., 
2014). We, therefore, adopted the system-GMM dynamic approach and 
estimated overall population health using the following equation (Gerry 
et al., 2014): 
AMit = β0 + β1AMi,t− 1 + β2Xit + εit 
The selection of the independent variables was based on two main 
factors: 1) a comprehensive review of the literature; and 2) constructing 
a model that was as representative as possible, while accounting for the 
most common factors associated with amenable mortality and taking 
into account variables that are a function of the increased healthcare 
spending during our study period (Conti and Ginja, 2017). We used the 
logarithm of age-adjusted amenable mortality as a dependent variable in 
this exercise. We assumed that the dependent variable was 
state-dependent, and so we included an auto-regressive term (i.e. a 
lagged value of the dependent variable). More specifically, as noted in 
our third research objective, one of the main goals of this work was to 
explore the link between amenable mortality and health inputs that are a 
function of increased healthcare expenditure. To take account of this, 
our set of independent variables includes: density of specialist physi-
cians and nurses and the availability of hospital beds per 100,000 
population. We selected these variables as their density increased during 
the study period, due to an increase in overall healthcare spending Conti 
and Ginja (2017); Knaul et al. (2012); INEGI (2019)). Moreover, these 
are the most common healthcare inputs used in analytical endeavours in 
the context of low and middle income countries (World Development 
Indicators, 2021). In addition, and to account for the level of 
socio-economic development across federal units, we also included the 
level of development reflected by the Gross Regional Product (GRP) per 
capita, in real terms. We did not age-standardize the independent vari-
ables, following the established practice in cross-regional research 
Table 1 
List of causes/diseases branded as ‘amenable’.  
Mortality causes Age 
groups 
International Classification of 
Diseases (ICD) 10th revision 
Infectious diseases 
Intestinal infections 0–14 A00-A09 
Tuberculosis 0–74 A15-A19 
Other infections (diphtheria, 
tetanus, septicaemia, poliomyelitis) 
0–74 A36,A35, A80 
Whooping cough 0–14 A37 
Measles 1–14 B05 
Tumours 
Malignant neoplasm of colon and 
rectum 
0–74 C18–C21 
Malignant neoplasm of skin 0–74 C44 
Malignant neoplasm of breast 0–74 C50 
Malignant neoplasm of cervix uteri 0–74 C53 
Malignant neoplasm of cervix uteri 
and body of uterus 
0–74 C54, C55 
Malignant neoplasm of testis 0–74 C62 
Hodgkin’s disease 0–74 C81 
Leukaemia 0–44 C91–C95 
Diabetes 0–49 E10-E14 
Ischaemic heart disease: 50% of 
deaths 
0–74 I20–I25 
Other circulatory disease 
Chronic rheumatic heart disease 0–74 I05–I09 
Hypertensive heart disease 0–74 I10–I13, I15 
Cerebrovascular disease 0–74 I60–I69 
Respiratory disease 
Respiratory diseases (excluding 
pneumonia and influenza) 
1–14 J00-J09, J20-J99 
Influenza 0–74 J10-J11 
Pneumonia 0–74 J12-J18 
Surgical conditions 
Peptic ulcer disease 0–74 K25–K27 
Appendicitis 0–74 K35–K38 
Abdominal hernia 0–74 K40–K46 
Cholelithiasis and Cholecystitis 0–74 K80–K81 
Nephritis and nephrosis 0–74 N00–N07, N17–N19, N25–N27 
Benign prostatic hyperplasia 0–74 N40 
Misadventures to patients during 
surgical and medical care 
0–74 Y60–Y69, Y83–Y84 
Maternal, congenital and perinatal conditions 








Diseases of the thyroid 0–74 E00-E07 
Epilepsy 0–74 G40-G41 
Source: Nolte and McKee (2012) 
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(Gerry et al., 2014). 
We omitted health expenditure as one of the independent variables 
for the following reason: different levels of per capita health expenditure 
may translate into variable levels of health inputs per federal district, 
given differences both in health care consumption patterns and labour 
costs across the different regions or districts. In other words, two regions 
might spend the same per capita amount of health resources but on a 
different mix of inputs. Therefore, our selected supply-side independent 
variables – GPs, specialist physicians, nurses and hospital beds – capture 
how health care expenditure is translated into health care inputs. 
Nevertheless, in the supplementary materials we also report the results 
when including proxies for public health expenditure (i.e. regional real 
health expenditure per capita as well as regional health expenditure as a 
share of gross regional product). Further information about the sources 
of the variables is provided in Supplementary material. 
We used a system-GMM approach to address problems of endoge-
neity, such as: reversed causality, time-invariant heterogeneity, or un-
observed factors, which posed significant threats to the validity of the 
findings, potentially leading to biased estimates. In the case of reverse 
causality, for example, the density of GPs could have an impact on 
amenable mortality, but amenable mortality itself could also have an 
impact upon the authorities’ decision to allocate more (or fewer) health 
resources to a particular state. In addition, there may have been unob-
servable, constant factors, such as cultural practices, that could have an 
impact on amenable mortality, and result in unobserved heterogeneity. 
System-GMM has been used previously to assess cross-country de-
terminants of economic growth (Roodman, 2008). Further details on the 
technique and specification of the System-GMM are provided in Sup-
plementary material. 
All the analyses were done using STATA version 14 SE (StataCorp, 
College Station, Texas, USA). 
2.3. Ethical considerations 
The study was a mathematical modelling study based on aggregated 
data, and there were no study participants, so participant-informed 
consent and the need for ethics approval do not apply. 
3. Results 
3.1. Levels and trends of amenable mortality 
Table 2 summarizes the level and trends of amenable mortality, 
overall and by specific conditions, at a national level from 2000 to 2015 
(Supplementary material Table A1 summarizes the contribution of 
specific conditions to the overall amenable mortality rate). The overall 
age-standardized amenable mortality rate was 136.0 per 100,000 pop-
ulation in 2000 and 124.1 per 100,000 population in 2015, a 9% 
decrease. NCDs, including cardiovascular conditions, tumours, and 
diabetes accounted for more than 60% of amenable mortality. Cardio-
vascular diseases such as ischaemic heart disease had the highest 
amenable mortality rate with 55 deaths per 100,000 individuals in 
2015, accounting for approximately 44% of amenable deaths. Malignant 
neoplasms were the second largest contributor, accounting for 13% of 
all amenable deaths. Perinatal conditions and respiratory conditions, 
such as influenza and pneumonia, accounted for about 8% each. 
The change in cause-specific amenable mortality varied. For 
example, mortality rate due to cardiovascular conditions dropped by 
6%, while mortality rate due to perinatal conditions dropped by 30%. 
Marked improvements in the amenable mortality rate were also seen for 
other conditions. Mortality rate due to intestinal problems and tuber-
culosis decreased by 68% and 56% respectively. Conversely, respiratory 
diseases, especially influenza and pneumonia, increased markedly by 
5% and 6%, respectively. Mortality rate due to diabetes increased by 
22%, and as a result, diabetes accounted for 6% of the total amenable 
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Fig. 1 shows the rate of amenable mortality according to state in 
2000 and in 2015. There was an overall reduction in amenable mortality 
across states over the period of this study, but the reduction was varied 
across states. For example, amenable mortality dropped by a fifth in 
states such as Mexico City and Baja California, while it increased by 25% 
in Guerrero, by 20% in Campeche, and by 12% in Durango. However, 
the distribution of amenable mortality at state level was generally 
similar in 2000 and 2015. 
Changes in disease-specific mortality also varied across states. Only 
two states had a reduced incidence of diabetes-related amenable mor-
tality. In contrast, over half the states showed a decrease in mortality 
due to cardiovascular conditions. The largest change was in perinatal 
deaths: mortality decreased in approximately 90% of states. The dis-
aggregated data helped to explain the variability across various states. 
For example, deaths due to cardiovascular diseases (which accounted for 
almost half of the total amenable mortality) were highest in the northern 
states of Chihuahua, Sonora and Coahuila, which explains the higher 
amenable mortality in these states. While amenable mortality decreased 
in most states, in some states the overall amenable mortality increased 
due to rising numbers of deaths attributable to cardiovascular diseases 
and diabetes. Supplementary material Tables A2, A3 and A4 show the 
changes in mortality due to cardiovascular disease, diabetes and peri-
natal deaths, respectively. 
3.2. Results of the regression analysis and system Generalized Method of 
Moments 
Table 3 shows the associations between health system supply-side 
factors and amenable mortality according to the three models 
described in the Methods section. 
A number of findings emerged from the models. Firstly, the autore-
gressive term was positive and significant, suggesting persistence in the 
amenable mortality series (i.e. strong correlation between present and 
past values of the amenable mortality). In addition, the density of GPs 
and specialist physicians was negatively associated with amenable 
mortality rate. More specifically, a unit increase in the density of GPs 
and specialist physicians was associated with a 0.6% and 0.5% reduction 
in the overall amenable mortality, respectively. The system-GMM esti-
mates passed the necessary diagnostic tests to confirm its validity. More 
specifically, the Hansen test value was 0.502 and the parameter value 
for the autoregressive term (0.767) lay between the values obtained 
through fixed effects (0.470) and OLS (0.907), as expected. Finally, the 
estimates passed the general rule that the number of instruments was 
smaller than the number of groups used in the model. 
As mentioned in the methodological part of the paper, while our 
principal modelling does not include a proxy for public health expen-
diture, in Supplementary material Table A5 and A6 we also report the 
findings with the inclusion of proxies for public health expenditure (real 
public health spending per capita and public health expenditure as a 
share of gross regional product) as independent variables. The findings 
suggest that the public health expenditure variable is insignificant, 
without affecting the sign and significance of the other variables in the 
model. 
4. Discussion 
Our study has some important findings. First, we found a 9% drop in 
the national level of amenable mortality. Second, there was significant 
heterogeneity in levels and trends of amenable mortality across various 
states. This heterogeneity across states explains the small change in 
amenable mortality at a national level. Lastly, the results from the 
analytical model showed that the density of GPs and specialist physi-
cians at a state level was associated with lower amenable mortality. 
At national level, the reduction in amenable mortality in Mexico 
found in this study is less than that experienced in other middle- and 
high-income countries. For example, Nolte and McKee (2012) found a 
considerably greater reduction in amenable mortality in three European 
countries and the US over a similar time period. Between 1999 and 
2007, amenable mortality among men fell by the following amounts: 
France 27.7%, Germany 24.3%, UK 36.9% and US 18.5%. Among 
women, similar decreases were also recorded: France 23.4%, Germany 
22.7%, UK 31.9%, and US 17.5%. Similarly, in Brazil, Hone et al. (2017) 
found a 20% reduction in amenable mortality from municipalities with 
the lowest governance score, rising to 26% in municipalities with the 
highest governance score over the period 2000–2012. However, their 
analysis only included about one quarter of the 5565 municipalities in 
the country. 
We found significant heterogeneity in levels of amenable mortality 
across different states. The amenable mortality was highest in northern 
states, mostly due to higher mortality resulting from diabetes and car-
diovascular diseases. This result is consistent with the results of a recent 
study which found that the northern and central states of Mexico had the 
highest rates of obesity, diabetes, and mortality from ischaemic heart 
disease (González-Pier et al., 2016). Furthermore, this is in line with the 
findings by Aburto et al. (2016) who also found that mortality due to 
ischaemic heart disease is higher in the northern states. 
Our study also documented different trends in amenable mortality 
across states. Although there was significant heterogeneity in amenable 
mortality across states, some causes of amenable mortality such as 
tuberculosis, perinatal illnesses and cervical and breast cancer, 
decreased in almost all states. This is consistent with the results of a 
study, which found a decrease in perinatal mortality in Mexico (Aburto 
et al., 2018). Some of the reasons for the reduction in perinatal mortality 
may be programmes such as “Hospital Amigo del Niño y la Niña” (Boy 
and Girl Hospital Friend) initiative, “Maternal Lactation Education”, and 
the implementation of maternal milk banks. Furthermore, economic 
development is known to be associated with a reduction in childhood 
mortality, and Mexico had a cumulative growth in GDP of 8.3% during 
the study period (Bhalotra, 2006). 
However, while perinatal mortality dropped, mortality due to NCDs 
such as diabetes rose in most states during the study period. Aburto, 
Riffe, and Canudas-Romo (Aburto et al., 2018) found that the increase in 
diabetes paralleled the sharp increase in obesity rates in the country. The 
rise in deaths attributable to diabetes has paralleled a rise in the diabetes 
prevalence rate. Official data suggests that the prevalence of diabetes at 
national level has witnessed a steady rise from 7.5% in 2000 to 12.6% in 
2013 (IDF, 2015). Importantly, mortality due to diabetes has increased 
despite the continuing policy efforts of the national authorities such as 
the National Action Plan for Diabetes (2001–2006) which led to the 
creation of “Grupos de Mutua Ayuda” in each state to provide education, 
metabolic control, and adherence to treatment, for people with diabetes. 
The more recent National Plan for Diabetes (2007–2012) – including 
mass media campaigns for self-care, active screening and care cam-
paigns – has not translated into a sufficient reduction of increased risk 
for mortality associated with obesity (Secretaria de Salud, 2011). 
Our results show that primary health care (measured using the 
density of GPs as a proxy) was related to amenable mortality. Using a 
cross-country regression analysis for 18 wealthy OCED countries, Mac-
inko et al. (2003) found that the number of doctors per 100,000 popu-
lation was negatively associated with all-cause premature mortality. 
Similarly, in Germany, Sundmacher (Sundmacher and Busse, 2011) 
found that higher physician supply was associated with significantly 
lower avoidable cancer mortality. Basu et al. (2019) found that a total of 
10 additional primary care physicians per 100,000 population in the US 
was associated with reductions in cardiovascular, cancer, and respira-
tory mortality of 0.9%, 1.0% and 1.4%, respectively. Finally, we found 
that the density of specialist physicians was negatively associated with 
amenable mortality. In the Mexican context, a significant number of 
specialist physicians operate at office-based practices or have a dual 
hospital-primary care practice (OECD, 2016). Increasing the number of 
GPs and specialist physicians could further reduce amenable mortality. 
As previously stated, in this paper we only take into consideration 
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Fig. 1. Amenable mortality rate in Mexico in 2000 and 2015 by state.  
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amenable mortality, i.e. mortality due to conditions amenable to med-
ical care. While there has been a burgeoning literature on the impact of 
preventive interventions (e.g. access to clean water and clean sanitation) 
or other, system-wide policies, which would prevent deaths like homi-
cides (Aburto and Beltrán-Sánchez, 2019), these broader definitions of 
avoidable mortality fall outside this paper’s remit. 
There are some limitations to this study. While previous evidence 
indicates that socioeconomic factors such as inequality and level of 
education are significant determinants of health outcomes, we did not 
include them in the model, because the available data was inconsistent 
by year and the quality was limited. We used only the most common 
correlates of amenable mortality. The quality of the data used could also 
be considered as an additional limitation to this work, but the approach 
adopted mitigated some of these risks. Firstly, by taking into account 
deaths occurring below the age of 75 and causes of deaths that mostly 
affect adults, we reduced some of the imprecision associated with death 
counts, particularly for the older population (over 85) and for children 
(Aburto et al., 2016). Second, while changes over time in the reporting 
of causes of death could also be mentioned as problematic in Mexico, the 
ICD-10 chapter level underlying the cause of death codes used in our 
analysis is reported as capable of returning reliable estimates of the 
disease burden in the population, as previously documented in existing 
research (Wright, 2017). However, there are some limitations regarding 
the link between amenable mortality and enrolment in various health 
insurance schemes (e.g. Seguro Popular, IMSS), which, given the nature 
of the data we used, cannot be tackled in this paper. 
5. Conclusion and policy implications 
This study assessed the trends in amenable mortality in Mexico over 
the period 2000–2015, at national and state levels, and assessed the 
determinants of these trends. The decrease in amenable mortality over 
the study period was driven mostly by a reduction in diseases of 
childhood. We also found a significant increase in amenable mortality 
due to diabetes during a period when the prevalence of diabetes was also 
increasing. Finally, using a state-level panel data analysis, we found a 
strong negative association between the density of GPs and specialist 
physicians and amenable mortality. 
Based on the association between physician density and amenable 
mortality reduction, it is recommended that Mexico allocates more re-
sources to primary care, to match similarly sized economies. Currently 
not all Mexican citizens register with a primary care doctor and primary 
care has not been developed as a distinct medical specialty (OECD, 
2016). Mexico only has 2.2 practising physicians per 1000 population, 
and although it is comparable to the density of physicians in Brazil (2.1), 
it is much lower than that of Argentina (3.9) (OECD, 2016). More re-
sources and better training could increase physician availability and 
access in disadvantaged areas and reduce dependence on the hospital 
sector, thus contributing to further reductions in amenable mortality. 
At the start of 2020, SP was replaced by Health Institute for Well-
being (INSABI), which should allow all Mexican citizens to access public 
hospitals or clinics without paying, while also covering the cost of 
medications (Agren, 2020). To what extent this policy change will 
contribute to further reduction in amenable mortality remains to be 
seen. 
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Agueldo-Botero, M., González, R.R.S., López, J.A.M., 2015. Mortalidad evitable en los 
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Ciênc saúde coletiva 20 (4), 1063–1073. https://doi.org/10.1590/1413- 
81232015204.13782014. 
Alvarez, J.A., et al., 2019. Latin American convergence and divergence towards the 
mortality profiles of developed countries. Popul. Stud. 1–18. 
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